NM_001943.5:c.2318G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001943.5(DSG2):​c.2318G>A​(p.Arg773Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.292 in 1,376,676 control chromosomes in the GnomAD database, including 55,785 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R773G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.23 ( 4237 hom., cov: 26)
Exomes 𝑓: 0.30 ( 51548 hom. )

Consequence

DSG2
NM_001943.5 missense

Scores

2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:18

Conservation

PhyloP100: 1.83

Publications

40 publications found
Variant links:
Genes affected
DSG2 (HGNC:3049): (desmoglein 2) This gene encodes a member of the desmoglein family and cadherin cell adhesion molecule superfamily of proteins. Desmogleins are calcium-binding transmembrane glycoprotein components of desmosomes, cell-cell junctions between epithelial, myocardial, and other cell types. The encoded preproprotein is proteolytically processed to generate the mature glycoprotein. This gene is present in a gene cluster with other desmoglein gene family members on chromosome 18. Mutations in this gene have been associated with arrhythmogenic right ventricular dysplasia, familial, 10. [provided by RefSeq, Jan 2016]
DSG2-AS1 (HGNC:51311): (DSG2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026043653).
BP6
Variant 18-31542836-G-A is Benign according to our data. Variant chr18-31542836-G-A is described in ClinVar as Benign. ClinVar VariationId is 44300.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.46 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001943.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DSG2
NM_001943.5
MANE Select
c.2318G>Ap.Arg773Lys
missense
Exon 14 of 15NP_001934.2
DSG2-AS1
NR_045216.1
n.1810+266C>T
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DSG2
ENST00000261590.13
TSL:1 MANE Select
c.2318G>Ap.Arg773Lys
missense
Exon 14 of 15ENSP00000261590.8
DSG2
ENST00000713817.1
c.2309G>Ap.Arg770Lys
missense
Exon 15 of 16ENSP00000519121.1
DSG2
ENST00000713819.1
c.2309G>Ap.Arg770Lys
missense
Exon 16 of 17ENSP00000519123.1

Frequencies

GnomAD3 genomes
AF:
0.230
AC:
32204
AN:
140046
Hom.:
4233
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.0830
Gnomad AMI
AF:
0.161
Gnomad AMR
AF:
0.283
Gnomad ASJ
AF:
0.179
Gnomad EAS
AF:
0.476
Gnomad SAS
AF:
0.262
Gnomad FIN
AF:
0.383
Gnomad MID
AF:
0.199
Gnomad NFE
AF:
0.267
Gnomad OTH
AF:
0.223
GnomAD2 exomes
AF:
0.265
AC:
53755
AN:
202736
AF XY:
0.264
show subpopulations
Gnomad AFR exome
AF:
0.0722
Gnomad AMR exome
AF:
0.281
Gnomad ASJ exome
AF:
0.169
Gnomad EAS exome
AF:
0.467
Gnomad FIN exome
AF:
0.335
Gnomad NFE exome
AF:
0.255
Gnomad OTH exome
AF:
0.249
GnomAD4 exome
AF:
0.299
AC:
369845
AN:
1236560
Hom.:
51548
Cov.:
35
AF XY:
0.298
AC XY:
181338
AN XY:
608972
show subpopulations
African (AFR)
AF:
0.0874
AC:
2101
AN:
24046
American (AMR)
AF:
0.311
AC:
9173
AN:
29490
Ashkenazi Jewish (ASJ)
AF:
0.233
AC:
3837
AN:
16500
East Asian (EAS)
AF:
0.559
AC:
18712
AN:
33484
South Asian (SAS)
AF:
0.245
AC:
18050
AN:
73696
European-Finnish (FIN)
AF:
0.395
AC:
17016
AN:
43090
Middle Eastern (MID)
AF:
0.205
AC:
924
AN:
4502
European-Non Finnish (NFE)
AF:
0.296
AC:
285310
AN:
964084
Other (OTH)
AF:
0.309
AC:
14722
AN:
47668
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
13256
26512
39768
53024
66280
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9884
19768
29652
39536
49420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.230
AC:
32211
AN:
140116
Hom.:
4237
Cov.:
26
AF XY:
0.238
AC XY:
16033
AN XY:
67414
show subpopulations
African (AFR)
AF:
0.0830
AC:
3097
AN:
37324
American (AMR)
AF:
0.283
AC:
3659
AN:
12930
Ashkenazi Jewish (ASJ)
AF:
0.179
AC:
605
AN:
3388
East Asian (EAS)
AF:
0.476
AC:
2207
AN:
4634
South Asian (SAS)
AF:
0.259
AC:
1062
AN:
4098
European-Finnish (FIN)
AF:
0.383
AC:
3386
AN:
8844
Middle Eastern (MID)
AF:
0.197
AC:
52
AN:
264
European-Non Finnish (NFE)
AF:
0.267
AC:
17554
AN:
65814
Other (OTH)
AF:
0.230
AC:
447
AN:
1940
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1108
2216
3324
4432
5540
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.244
Hom.:
16444
Bravo
AF:
0.209
TwinsUK
AF:
0.263
AC:
974
ALSPAC
AF:
0.259
AC:
998
ESP6500AA
AF:
0.0778
AC:
307
ESP6500EA
AF:
0.254
AC:
2109
ExAC
AF:
0.259
AC:
31247
Asia WGS
AF:
0.344
AC:
1197
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:18
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:9
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Apr 08, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Nov 07, 2007
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 33047533)

Nov 21, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Cardiomyopathy Benign:2
Apr 08, 2018
Color Diagnostics, LLC DBA Color Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 23, 2022
Cohesion Phenomics
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Arrhythmogenic right ventricular dysplasia 10 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Arrhythmogenic right ventricular cardiomyopathy Benign:1
Oct 02, 2024
All of Us Research Program, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cardiovascular phenotype Benign:1
Mar 11, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
18
DANN
Benign
0.94
DEOGEN2
Benign
0.13
T
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.55
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.55
T
MetaRNN
Benign
0.0026
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
1.8
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.35
N
REVEL
Benign
0.092
Sift
Benign
0.38
T
Sift4G
Benign
0.31
T
Polyphen
0.026
B
Vest4
0.020
MPC
0.074
ClinPred
0.0055
T
GERP RS
2.2
Varity_R
0.037
gMVP
0.36
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2278792; hg19: chr18-29122799; COSMIC: COSV55203380; API